Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD). (Q33342930)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD). |
scientific article |
Statements
1 reference
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD). (English)
1 reference
F Graziano
1 reference
F FerraĆ¹
1 reference
V Catalano
1 reference
C Massacesi
1 reference
R R Silva
1 reference
S Barni
1 reference
A Zaniboni
1 reference
N Battelli
1 reference
S Siena
1 reference
P Giordani
1 reference
D Mari
1 reference
A M Baldelli
1 reference
S Antognoli
1 reference
R Maisano
1 reference
D Priolo
1 reference
M A Pessi
1 reference
S Rota
1 reference
1 May 2002
1 reference
1 reference
13
1 reference
716-720
1 reference
Identifiers
1 reference
1 reference